杭州启明医疗器械股份有限公司 VENUS MEDTECH (HANGZHOU) INC.
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Venus Medtech Launches Global Advisory Board to Target for International Market 2018-09-25 00:00
Venus Medtech Enters North American Market 2018-06-14 13:12
Venus Medtech's strategic investment in Keystone Heart deepens the technical layout of cerebral embolic protection market 2018-05-24 01:14
Venus Medtech Receives DCP Capital's Equity Investment to Accelerate Heart Valve Technology Development and International Commercialization 2018-05-16 10:05
First Successful Clinical Implantation of Transcatheter Pulmonary Valve VenusP-Valve was Successfully Completed in Brazil 2017-12-23 02:02
China successfully completes the country's first human implantation of a retrievable transcatheter aortic valve 2017-11-28 21:00
Venus Medtech Acquires U.S. Company InterValve to Create a Systematic TAVR Treatment and Strengthen Global Expansion 2017-06-14 22:21
Venus Medtech's TAVR Device Is Approved By CFDA, Creating A New Era Of Interventional Cardiology In China 2017-04-28 21:45
The Successful Worldwide First in Human Implantation of an Innovative Aortic Valve from Colibri Heart Valve and Venus Medtech with Disruptive "Dry Tissue" Technology Conducted 2016-10-28 10:42
Venus Medtech's Transcatheter Pulmonary Valve Debuts in Europe, Marking the Start of Global Clinical Trial 2016-09-19 13:18
First Ever Venus P-Valve Implantations in Latin America 2016-04-06 21:10
Venus Medtech Receives Investment from Goldman Sachs, and Establishes Cardiac Valve Research Institute Together with the Second Affiliated Hospital of Zhejiang University 2016-03-25 15:03
1 2